Search Results - Petr Pavlicek

  • Showing 1 - 7 results of 7
Refine Results
  1. 1

    INFANT EXTRAMEDULLARY KMT2A REARRANGED T/MYELOID ACUTE LEUKEMIA MIMICKING LANGERHANS CELL HISTIOCYTOSIS by Barbora Vakrmanova, Ester Mejstrikova, Jakub Jonas, Petr Pavlicek, Marketa Zaliova, Marek Turnovec, Livia Molcanyova, Eva Fronkova, Ondrej Hrusak, Lucie Sramkova

    Published in EJC Paediatric Oncology (2023-12-01)
    Get full text
    Article


  2. 2

    P1294: REAL-WORLD OUTCOMES OF 2149 NEWLY DIAGNOSED TRANSPLANT-ELIGIBLE MULTIPLE MYELOMA PATIENTS by Tereza Popková, Ludek Pour, Ivan Spicka, Jakub Radocha, Alexandra Jungova, Jiri Minarik, Petr Pavlíček, Tomas Jelínek, Marta Krejčí, Jan Straub, Vladimir Maisnar, Tereza Dekojová, Tomáš Pika, Jan Soukup, Lenka Pospíšilová, Roman Hájek

    Published in HemaSphere (2023-08-01)
    Get full text
    Article


  3. 3

    Unexpected Heterogeneity of Newly Diagnosed Multiple Myeloma Patients with Plasmacytomas by Martin Stork, Sabina Sevcikova, Tomas Jelinek, Jiri Minarik, Jakub Radocha, Tomas Pika, Lenka Pospisilova, Ivan Spicka, Jan Straub, Petr Pavlicek, Alexandra Jungova, Zdenka Knechtova, Viera Sandecka, Vladimir Maisnar, Roman Hajek, Ludek Pour

    Published in Biomedicines (2022-10-01)
    Get full text
    Article


  4. 4

    Lenalidomide based triplets in relapsed/refractory multiple myeloma: analysis of the Czech Myeloma Group by Jiri Minarik, Ludek Pour, Vojtech Latal, Tomas Jelinek, Jan Straub, Alexandra Jungova, Jakub Radocha, Petr Pavlicek, Martin Stork, Tomas Pika, Petra Krhovska, Tereza Popkova, Frantisek Sedlak, Ivan Spicka, Pavel Jindra, Vladimira Capounova, Vladimir Maisnar, Roman Hajek

    Published in BMC Cancer (2025-04-01)
    Get full text
    Article


  5. 5

    Validation of multiple myeloma risk stratification indices in routine clinical practice: Analysis of data from the Czech Myeloma Group Registry of Monoclonal Gammopathies by Jakub Radocha, Vladimír Maisnar, Luděk Pour, Ivan Špička, Jiři Minařík, Lenka Szeligová, Petr Pavlíček, Alexandra Jungová, Marta Krejčí, Tomáš Pika, Jan Straub, Lucie Brožová, Lukáš Stejskal, Adriana Heindorfer, Pavel Jindra, Petr Kessler, Peter Mikula, Michal Sýkora, Marek Wróbel, Jiří Jarkovský, Roman Hájek

    Published in Cancer Medicine (2018-08-01)
    Get full text
    Article


  6. 6

    Clinical characteristics and outcomes in risk-stratified patients with smoldering multiple myeloma: data from the Czech Republic Registry of Monoclonal Gammopathies by Viera Sandecka, Tereza Popkova, Martin Stork, Vladimir Maisnar, Jiri Minarik, Alexandra Jungova, Petr Pavlicek, Lukas Stejskal, Lenka Pospisilova, Adriana Heindorfer, Jarmila Obernauerova, Evzen Gregora, Michal Sykora, Jana Ullrychova, Marek Wrobel, Petr Kessler, Tomas Jelinek, Peter Kunovszki, Sacheeta Bathija, Blanca Gros, Sabine Wilbertz, Qian Cai, Annette Lam, Ivan Spicka

    Published in Blood Cancer Journal (2023-09-01)
    Get full text
    Article


  7. 7

    Survival benefit of ixazomib, lenalidomide and dexamethasone (IRD) over lenalidomide and dexamethasone (Rd) in relapsed and refractory multiple myeloma patients in routine clinical... by Jiri Minarik, Tomas Pika, Jakub Radocha, Alexandra Jungova, Jan Straub, Tomas Jelinek, Ludek Pour, Petr Pavlicek, Martin Mistrik, Lucie Brozova, Petra Krhovska, Katerina Machalkova, Pavel Jindra, Ivan Spicka, Hana Plonkova, Martin Stork, Jaroslav Bacovsky, Lenka Capkova, Michal Sykora, Petr Kessler, Lukas Stejskal, Adriana Heindorfer, Jana Ullrychova, Tomas Skacel, Vladimir Maisnar, Roman Hajek

    Published in BMC Cancer (2021-01-01)
    Get full text
    Article


Search Tools: